• Open CHF368.25
  • Day Range 368.25 - 370.45
  • 52 Week Range 290.55 - 374.70
  • Market Cap CHF319.69B
  • Shares Outstanding N/A
  • Public Float 684.75M
  • Beta 0.95
  • Rev. per Employee CHF574.81K
  • P/E Ratio 22.72
  • EPS CHF16.25
  • Yield 2.46%
  • Dividend CHF9.10
  • Ex-Dividend Date Mar 18, 2021
  • Short Interest N/A
  • % of Float Shorted N/A
  • Average Volume 1.13M
5 Day
  • 1.95%
1 Month
  • 4.29%
3 Month
  • 18.16%
YTD
  • 19.48%
1 Year
  • 12.53%

Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience. The Diagnostic segment refers to diagnosis of diseases through an in vitro diagnostics process. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.